rs772013916

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 8P and 5B. PVS1BS1_SupportingBS2

The NM_001723.7(DST):​c.6047_6048dupAG​(p.Ile2017fs) variant causes a frameshift, splice region change. The variant allele was found at a frequency of 0.000708 in 1,612,024 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00044 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00074 ( 2 hom. )

Consequence

DST
NM_001723.7 frameshift, splice_region

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 4.34

Publications

0 publications found
Variant links:
Genes affected
DST (HGNC:1090): (dystonin) This gene encodes a member of the plakin protein family of adhesion junction plaque proteins. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene, but the full-length nature of some variants has not been defined. It has been reported that some isoforms are expressed in neural and muscle tissue, anchoring neural intermediate filaments to the actin cytoskeleton, and some isoforms are expressed in epithelial tissue, anchoring keratin-containing intermediate filaments to hemidesmosomes. Consistent with the expression, mice defective for this gene show skin blistering and neurodegeneration. [provided by RefSeq, Mar 2010]
DST Gene-Disease associations (from GenCC):
  • hereditary sensory and autonomic neuropathy type 6
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.000736 (1074/1459806) while in subpopulation SAS AF = 0.00152 (131/86214). AF 95% confidence interval is 0.00131. There are 2 homozygotes in GnomAdExome4. There are 522 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DSTNM_001723.7 linkc.6047_6048dupAG p.Ile2017fs frameshift_variant, splice_region_variant Exon 23 of 24 ENST00000370765.11 NP_001714.1 Q03001-3
DSTNM_001374736.1 linkc.4930-3503_4930-3502dupAG intron_variant Intron 36 of 103 ENST00000680361.1 NP_001361665.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DSTENST00000370765.11 linkc.6047_6048dupAG p.Ile2017fs frameshift_variant, splice_region_variant Exon 23 of 24 1 NM_001723.7 ENSP00000359801.6 Q03001-3
DSTENST00000680361.1 linkc.4930-3503_4930-3502dupAG intron_variant Intron 36 of 103 NM_001374736.1 ENSP00000505098.1 A0A7P0T890

Frequencies

GnomAD3 genomes
AF:
0.000440
AC:
67
AN:
152100
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000794
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000497
AC:
125
AN:
251270
AF XY:
0.000560
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000678
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000736
AC:
1074
AN:
1459806
Hom.:
2
Cov.:
31
AF XY:
0.000719
AC XY:
522
AN XY:
726416
show subpopulations
African (AFR)
AF:
0.0000898
AC:
3
AN:
33426
American (AMR)
AF:
0.000112
AC:
5
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26116
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39692
South Asian (SAS)
AF:
0.00152
AC:
131
AN:
86214
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53410
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5766
European-Non Finnish (NFE)
AF:
0.000806
AC:
895
AN:
1110128
Other (OTH)
AF:
0.000497
AC:
30
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
50
100
151
201
251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000440
AC:
67
AN:
152218
Hom.:
0
Cov.:
32
AF XY:
0.000484
AC XY:
36
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.0000963
AC:
4
AN:
41546
American (AMR)
AF:
0.000262
AC:
4
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000794
AC:
54
AN:
68004
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000772
Hom.:
0
Bravo
AF:
0.000476
EpiCase
AF:
0.000763
EpiControl
AF:
0.000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary sensory and autonomic neuropathy type 6;C3809470:Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency Uncertain:1
Jan 07, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (Splice site) in the DST gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 633 amino acid(s) of the DST protein. This variant is present in population databases (rs772013916, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with DST-related conditions. ClinVar contains an entry for this variant (Variation ID: 474536). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
Apr 15, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Frameshift variant predicted to result in abnormal protein length as the last 633 amino acids are replaced with 1 different amino acids, and other similar variants have been reported in HGMD; Has not been previously published as pathogenic or benign to our knowledge -

DST-related disorder Uncertain:1
Dec 19, 2023
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The DST c.6047_6048dupAG variant is predicted to result in a frameshift and premature protein termination (p.Ile2017Argfs*2). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.14% of alleles in individuals of South Asian descent in gnomAD (including one homozygous record), which is likely too common for an undocumented disease-causing variant. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.3
Mutation Taster
=62/38
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs772013916; hg19: chr6-56482783; API